1. An unexpected and devastating adverse event of dasatinib: Rhabdomyolysis. (2016) Authors: Uz, Burak; Dolasik, Ilhan Journal: Leukemia research reports Issue: Volume 5(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Chronic lymphocytic lymphoma and concomitant renal cell carcinoma (Clear Cell Type): Review of the literature. (2016) Authors: Uz, Burak; Dolasik, Ilhan; Ucer, Ozlem; Dagli, Adile Ferda; Simsek, Sercan Journal: Leukemia research reports Issue: Volume 6(2016) Page Start: 8 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Comment: Management of De Novo Chronic Myelogenous Leukemia and Imatinib-Induced Acute Rhabdomyolysis With the Second-Generation Tyrosine Kinase Inhibitor Dasatinib. (April 2016) Authors: Uz, Burak; Dolasik, Ilhan Journal: Annals of pharmacotherapy Issue: Volume 50:Number 4(2016:Apr.) Page Start: 334 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Decreased serum heat shock protein 60 levels in newly diagnosed immune thrombocytopenia patients. (18th April 2014) Authors: Dolasik, Ilhan; Birtas Atesoglu, Elif; Tarkun, Pinar; Mehtap, Ozgur; Keski, Hakan; Dogru, Atalay; Hacihanefioglu, Abdullah Journal: Platelets Issue: Volume 26:Number 3(2015:May) Page Start: 220 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗